Abstract

BackgroundGestational diabetes mellitus (GDM) is associated with adverse pregnancy outcomes. It is known that GDM is associated with an altered placental function and changes in placental gene regulation. More recent studies demonstrated an involvement of epigenetic mechanisms. So far, the focus regarding placental epigenetic changes in GDM was set on gene-specific DNA methylation analyses. Studies that robustly investigated placental global DNA methylation are lacking. However, several studies showed that tissue-specific alterations in global DNA methylation are independently associated with type 2 diabetes. Thus, the aim of this study was to characterize global placental DNA methylation by robustly measuring placental DNA 5-methylcytosine (5mC) content and to examine whether differences in placental global DNA methylation are associated with GDM.MethodsGlobal DNA methylation was quantified by the current gold standard method, LC-MS/MS. In total, 1030 placental samples were analyzed in this single-center birth cohort study.ResultsMothers with GDM displayed a significantly increased global placental DNA methylation (3.22 ± 0.63 vs. 3.00 ± 0.46 %; p = 0.013; ±SD). Bivariate logistic regression showed a highly significant positive correlation between global placental DNA methylation and the presence of GDM (p = 0.0009). Quintile stratification according to placental DNA 5mC levels revealed that the frequency of GDM was evenly distributed in quintiles 1–4 (2.9–5.3 %), whereas the frequency in the fifth quintile was significantly higher (10.7 %; p = 0.003). Bivariate logistic models adjusted for maternal age, BMI, ethnicity, recurrent miscarriages, and familiar diabetes predisposition clearly demonstrated an independent association between global placental DNA hypermethylation and GDM. Furthermore, an ANCOVA model considering known predictors of DNA methylation substantiated an independent association between GDM and placental DNA methylation.ConclusionsThis is the first study that employed a robust quantitative assessment of placental global DNA methylation in over a thousand placental samples. The study provides large scale evidence that placental global DNA hypermethylation is associated with GDM, independent of established risk factors.

Highlights

  • Gestational diabetes mellitus (GDM) is associated with adverse pregnancy outcomes

  • It is known that GDM is associated with altered placental gene regulation, and there is data indicating an involvement of epigenetic mechanisms [9,10,11,12,13]

  • In summary, this study provides the first large scale evidence that placental global DNA hypermethylation is associated with GDM independent of established risk factors

Read more

Summary

Introduction

Gestational diabetes mellitus (GDM) is associated with adverse pregnancy outcomes. It is known that GDM is associated with an altered placental function and changes in placental gene regulation. The focus regarding placental epigenetic changes in GDM was set on gene-specific DNA methylation analyses. Several studies showed that tissue-specific alterations in global DNA methylation are independently associated with type 2 diabetes. The increased risk for adverse pregnancy outcome in GDM may be associated with these placental structural and functional changes. The focus regarding placental epigenetic changes in GDM was predominantly set on gene specific DNA methylation [10,11,12,13]. There are no large scale clinical studies that characterized global placental DNA methylation, assessed by an absolute quantification of the genomic 5-methylcytosine (5mC) content, in healthy and GDM afflicted pregnancies [24]. The aim of this study was to analyze global DNA methylation in over a thousand placental samples by the current gold standard method, LC-MS/MS, to truly asses the degree of global placental DNA methylation in uncomplicated pregnancies and to investigate whether GDM is associated with alterations in global placental DNA methylation

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call